Close monitoring of a patient’s vital signs is a cornerstone of good care, but it can be difficult to do reliably in many settings. Houston-based startup Vitls has developed a disposable wearable and companion platform that allow doctors and nurses to remotely monitor a patient’s heart rate, temperature, respiration, and blood oxygenation.
1. Improved Patient Care
According to Werner Vorster, founder of Vitls, the vast majority of medical-grade monitors that hospitals use are large and clunky devices that patients hate wearing—and hospitals hate having to use. He wants to change that with a new kind of device that monitors vital signs continuously, allows patients to participate in clinical trials from home, and can be used by healthcare practices as part of their remote patient monitoring programs.
Real-time monitoring enables early detection of deterioration, which can help reduce hospital stays and treatment costs. In addition, it can improve outcomes and enhance patient satisfaction scores. The Vitls device consists of a flexible wearable patch that captures multi-parameter vital sign data including heart rate, respiration rate, blood oxygenation (SpO2), body temperature, movement, and sleep cycles. It is thin, discreet, waterproof, and disposable with a 6-day battery life. The information is wirelessly transmitted to a digital platform where a doctor or nurse can access it 24/7.
4. Increased Efficiency
Vitls was founded in 2016 by Werner Vorster, who recognised the need for a device that could provide patients with the close monitoring they needed without increasing hospital resources. His company’s FDA-cleared Tego device is a small, flexible wearable patch that monitors vital signs, such as heart rate, respiratory rate, body temperature, and blood oxygenation (SpO2), which are then transmitted to the Vitls app on a smartphone or tablet. Healthcare professionals can use the Vitls app to program instant notifications, view trends over time, and record notes that can then be synced with the patient’s EHR. Vitls’ technology also allows patients to continue their monitoring at home.